7/23/07
RALEIGH, N.C. – British banking and healthcare firm Misys plc has
announced the sale of two segments of its American-based healthcare
unit to focus on the ambulatory care market.
The company announced on Sunday that it sold its Tucson, Ariz-based
Diagnostic Systems business, including Misys Laboratory, Commercial
Laboratory and Clinical Financial products as well as stand-alone
systems for Radiology and Pharmacy departments, to Vista Equity
Partners, a San Francisco-based private equity firm, for $381.5 million.
“Our strategy, portfolio and organizational alignments are all
pointed toward the ambulatory space and the role that segment plays in
building connected healthcare communities,” said Vern Davenport,
executive vice president and general manager of Raleigh, N.C.
-based Misys Healthcare Systems, in a release posted on the company’s
Web site. “While we are justifiably proud of our reputation in the
diagnostic enterprise and the tremendous long-term relationships with
Misys Laboratory customers, we’re also willing to make the appropriate
business decisions in line with our focus on the ambulatory space.”
As part of the deal, the Diagnostic Systems business will enter
into a multi-year agreement to resell Misys Connect and market Misys
EMR as its preferred EMR solution for ambulatory physicians.
In another move announced Sunday, Misys is selling its San Bernardino, Calif.
-based Computerized Patient Records business to the Reston, Va.
-based QuadraMed Corporation for $33 million in cash.
QuadraMed officials welcomed the deal as an important addition to their company’s product line.
“Adding the CPR product to QuadraMed’s suite of healthcare
solutions is a key step in our plan to accelerate QuadraMed’s growth
while delivering on our care-based revenue cycle strategy,” QuadraMed
CEO Keith Hagen said in a statement. “As a result of this acquisition,
QuadraMed will be positioned to support the clinical information
systems needs of large complex hospitals and healthcare delivery
systems, particularly those focused on full clinical integration,
clinical decision support and Computerized Physician Order Entry
(CPOE).”
“These disposals rebalance our portfolio and enable us to
accelerate execution of our strategy,” Misys Chief Executive Mike
Lawrie said in a statement.
Misys, which had announced in March the launch of a three-to
five-year turnaround plan for its struggling healthcare unit, said
proceeds from both sales would be used to pay down debt, giving the
company maneuverability to make future business moves.
Lawrie, formerly of IBM and ValueAct Capital, came to Misys last
year following a failed management buyout by company founder Kevin
Lomax, which prompted his resignation.
News reports indicate the company also plans to announce this week
that it will shift to “open source” management, rather than selling
proprietary software.
Source:
Healthcare IT News
|